Finally, the effectiveness of CAV-mediated NaV1.1 expression was tested in a second DS mouse harboring the R613X nonsense mutation (Scn1aR613X/WT; refs. 62, 71). This evidence concerns the gene SCN1A and Dravet syndrome.